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Background: Alström Syndrome (AS) is a rare ciliopathy characterized by cone–rod retinal dystrophy, sensorineural
hearing loss, obesity, type 2 diabetes mellitus and cardiomyopathy. Most patients do not present with neurological
issues and demonstrate normal intelligence, although delayed psychomotor development and psychiatric disorders
have been reported. To date, brain Magnetic Resonance Imaging (MRI) abnormalities in AS have not been explored.
Methods: We investigated structural brain changes in 12 genetically proven AS patients (mean-age 22 years; range:
6–45, 6 females) and 19 matched healthy and positive controls (mean-age 23 years; range: 6–43; 12 females) using
conventional MRI, Voxel-Based Morphometry (VBM) and Diffusion Tensor Imaging (DTI).
Results: 6/12 AS patients presented with brain abnormalities such as ventricular enlargement (4/12), periventricular
white matter abnormalities (3/12) and lacune-like lesions (1/12); all patients older than 30 years had vascular-like
lesions. VBM detected grey and white matter volume reduction in AS patients, especially in the posterior regions.
DTI revealed significant fractional anisotropy decrease and radial diffusivity increase in the supratentorial white
matter, also diffusely involving those regions that appeared normal on conventional imaging. On the contrary, axial
and mean diffusivity did not differ from controls except in the fornix.
Conclusions: Brain involvement in Alström syndrome is not uncommon. Early vascular-like lesions, gray and white
matter atrophy, mostly involving the posterior regions, and diffuse supratentorial white matter derangement
suggest a role of cilia in endothelial cell and oligodendrocyte function.
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Alström syndrome (AS; OMIM#203800) is an autosomal
recessive rare disorder caused by mutations in ALMS1
(chromosome 2p13), with a frequency estimated at
<1:100.000 [1]. The syndrome is multisystemic and major
phenotypes include cone-rod retinal dystrophy leading to
blindness, hearing loss, obesity, type 2 diabetes mellitus
(T2DM), dilated cardiomyopathy, and progressive hepatic
and renal failure [1]. Fibrosis in multiple organs has been
described [1]. There is considerable variation in the
phenotypic spectrum both among and within different
families [1,2].
ALMS1 is ubiquitously expressed, but the function
remains unknown. At least one isoform of ALMS1
localizes to the centrosomes and basal bodies of ciliated
cells. Studies in murine and cellular models suggest that* Correspondence: valentinacitton@gmail.com
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reproduction in any medium, provided the ordefects in ciliogenesis and/or structure, function, or main-
tenance of cilia underlie the pathogenesis of AS [2,3].
ALMS1 is widely expressed in most regions of the brain
(http://www.brain-map.org/). Most AS patients demon-
strate normal intelligence, although some reports indicate
delayed early psychomotor and intellectual development.
Hearing and vision deficits probably contribute to learning
delays seen in some young children with AS. Motor
milestones are typically delayed by 1–2 years and there
may be deficits in coordination, balance, and fine motor
skills. A range of autism-spectrum behavior and clonic-
tonic or absence-seizure activity has been observed in
some cases. Major depression, hyperphagia, obsessive-
compulsive, and psychotic behaviors have been noted,
particularly in adults [1,2]. The mechanism underlying the
neurological involvement remains unknown in AS and
brain imaging has not been studied.
The aim of this study is to specifically investigate central
brain involvement by conventional Magnetic Resonancetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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diffusion tensor imaging (DTI) in a consistent group of
pediatric and adult patients affected by AS.
Patients and methods
Subjects
Twelve patients (mean-age 22 years; range: 6–45, 6 females)
affected with Alström Syndrome were recruited from our
Department of Internal Medicine (11 patients) and from
The Jackson Laboratory (1 patient). All the patients met
the diagnostic criteria for AS based on genetic analysis and
clinical observations [1] and had a normal intellectual
quotient.
Nineteen age- and gender-matched unrelated healthy
subjects or patients referred to neuroimaging for headache
with no history of prematurity, head trauma, neurological
or psychiatric disease and neurosurgery represented our
control group (mean age 23 years; range: 6–43; 12 females).
Two AS patients and 1 control were left-handed
according to the Edinburgh handedness inventory [4]. The
exclusion criteria were the presence of contraindications
to MRI and age < 6 years in order to avoid sedation. The
study was approved by the University Hospital of Padua
Ethics Committee and the Institutional Review Board of
The Jackson Laboratory. Written informed consent was
obtained from patients or their parents.
All subjects underwent a complete physical and neuro-
logical examination including neurosensory analysis
(retinopathy and hearing loss) and were investigated for
cardiovascular risk factors and comorbidities (obesity,
T2DM, cardiomyopathy, and hyperlipidemia). Clinical
findings are summarized in Table 1.
In particular, one patient (# 7) presented with mild
cardiac impairment since infancy.
All our subjects manifested a mild developmental
delay.
Image acquisition
For 11 patients and all controls, MRI scans were
performed at 1.5T (Achieva, Philips Medical Systems,
Best, the Netherlands) with a standard quadrature head
coil.
The MRI study protocol included:
1. 3DT1 weighted imaging (repetition time/echo time:
20/3.8 msec; flip angle: 20°; slice thickness: 1 mm,
pixel size: 0.66 × 0.66 mm);
2. Fluid-attenuated inversion-recovery (FLAIR,
repetition time/echo time: 10000/140 msec; echo
train length: 53; flip angle: 90°; slice thickness: 5 mm,
pixel size: 0.89 × 0.89 mm);
3. Diffusion tensor images acquired with a single-shot
echo planar diffusion weighted imaging according to
the following parameters: repetition time/ echo time:10389/80 ms, echo train length: 59; acquisition
matrix: 128 × 128, reconstructed voxel: 1.75 × 1.75 ×
2 mm, SENSE p reduction: 2, slice thickness: 2 mm
without gap, Number of Excitations: 2.
The axial sections covered the whole brain including the
cerebellum. The diffusion sensitizing gradients were applied
along 32 non-collinear gradient encoding directions with
maximum b = 800 s/mm2. One additional image without
diffusion gradients (b = 0 s/mm2) was also acquired.
Conventional MR images of patient #5 were collected
in another Center with a 1.5T scanner; this patient was
excluded from DTI and VBM analysis.
Image analysis
Grey matter preprocessing
We used the optimized VBM protocol available in the
statistical parametric mapping software (SPM8, http://
www.fil.ion.ucl.ac.uk/spm/) [5]. The protocol consisted of
the following: a study specific grey matter template
was built from the 30 segmented native images
affine-registered to the ICBM-152 grey matter template.
The native segmented images were then non-linearly
normalized onto this template, introducing a 'modulation'
for distortions due to the non-linear component of the
transformation by dividing each voxel of each registered
grey matter volume image by the Jacobian of the warp
field. The modulated normalized grey matter volume
images were then smoothed with an isotropic Gaussian
kernel with a sigma of 3 mm.
For statistical analyses, we used parametric t-test as
implemented by SPM8, using age as a covariate of no
interest. Results for grey matter were considered signifi-
cant for p < 0.06, after correction for multiple comparisons
using an initial cluster-threshold at p < 0.001 uncorrected
(minimum size = 20 voxels). Region of interest analyses
for hippocampal regions was performed using WFU-
PickAtlas 3.0.3while contrasts were analyzed using
SPM [6].
White matter preprocessing
All DTI data were preprocessed by the Oxford Center
for Functional MRI of the Brain (FMRIB)’s Diffusion
Toolbox (FDT) within FMRIB’s Software Library (FSL;
http://www.fmrib.ox.ac.uk/fsl/) [5]. First, the diffusion-
weighted volumes were aligned to its corresponding
non-diffusion-weighted (b0) image with an affine trans-
formation to minimize image distortion from eddy
currents and to reduce simple head motion. Then, non-
brain tissue and background noise were removed from
b0 image using the Brain Extraction Tool. After these
steps, the diffusion tensor for each voxel was estimated
by the multivariate linear fitting algorithm, and the
tensor matrix was diagonalized to obtain its three pairs







Overweight3 Hypertension4 Heart Ejection
fraction5
Dyslipidemia DM26 Hepatosteatosis Psisichiatric disorders P
1 6, M heterozygosis 8 and 16 + - ++ - normal - + - -
2 9, M heterozygosis 8 and 16 + + ++ - normal - + - -
3 11, F heterozygosis 8 + + + - normal - + + -
4 12, F heterozygosis 8 + + + - normal - + - -
5 13, F heterozygosis 8 and 16 ++ + + + normal + ++ + -
6 18, M heterozygosis 8 + + - - normal - + + -
7 23, M heterozygosis 10 + + + + 25% * + ++ + -
8 26, F heterozygosis 16 ++ + ++ + 47% - ++ + depression
9 29, F heterozygosis 8 and 16 ++ + + - normal + + + depression
10 31, M homozygosis 8 ++ + + + normal + - + anxiety,depression bulimia7
11 43, M homozygosis 8 ++ + + + normal + - + paranoid personality, disorder 8
12 45, F homozygosis 10 ++ + - + normal + ++ + -
1Vision Deficit: + = severe ipovision (< 1/20); ++ = blindness.
2Hearing Deficit: - = normal hearing; + = hearing deficit >20dB;
3Overweight: - = normal weight (Body Mass Index 18.5 to 25), + = overweight (Body Mass Index 25 to 30); ++ = obesity (Body Mass Index > 30).
4Hypertension: - = normotensive; + = under antihypertensive treatment.
5Heart ejection Fraction: normal value > 55%.
6++ = diabetes mellitus type 2, + = insulin resistance or hyperinsulinemia or impaired glucose tolerance.
7 Under therapy with valproic acid, bromazepam and Olanzapine.
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tional anisotropy (FA), mean diffusivity (MD), axial diffu-
sivity (L1: first eigenvalue), radial diffusivity (RA: average
of the second and third eigenvalue) were then generated.
Whole brain analysis of FA images was performed by
using Tract-Based Spatial Statistics (TBSS). In brief, FA
maps of all subjects were first realigned to a common
target and then the aligned FA volumes were normalized
to the Montreal Neurological Institute standard space
(MNI152). Thereafter, the registered FA images were
averaged to generate a cross-subject mean FA image,
and then the mean FA image was applied to create a
mean FA skeleton which represents the main fiber
tracks and the center of all fiber tracts common to the
group. The mean FA skeleton was further thresholded by
a FA value of 0.2 to exclude peripheral tracts where there
was significant inter-subject variability and/or partial vol-
ume effects with grey matter. Following the thresholding
of the mean FA skeleton, the aligned FA data of each par-
ticipant was projected onto the mean skeleton to create a
skeletonized FA map, by searching the area around the
skeleton in the direction perpendicular to each tract, and
finding the highest local FA value, and then assigning this
value to the corresponding skeletal structure.
To identify FA differences between AS patients and
controls, the skeletonized FA data were fed into the voxel-
wise statistics analysis which is based on non-parametric
approach utilizing permutation test theory. The testing
was performed by the FSL randomise program, which uses
5000 random permutations.
Age was entered into the analysis as a covariate.
Threshold-Free Cluster Enhancement (TFCE) approach
[7] was used to obtain the significant differences
between two groups at p ≤ 0.05, after accounting for
multiple comparisons by controlling for family-wise
error (FWE) rate.Figure 1 Brain MRI: coronal T1-weighted (a) and axial FLAIR (b, c) ima
atrophy with enlargement of ventricles and subarachnoid spaces; b) 11-yea
c) 18 year-old boy: bilateral dilated atria of the lateral ventricle.Results
Conventional MRI
None of the controls presented any parenchymal abnor-
mality except for an 18-year-old control who had brain
MRI because of headache and presented with mild
ventriculomegaly and a small aspecific white matter T2
hyperintense lesion on the left frontal lobe.
In the AS group, MRI revealed mild ventricular enlarge-
ment (two patients), mild ventricular enlargement with
increased subarachnoid spaces (one patient), isolated
enlargement of the left lateral ventricle (Figure 1).
Ventricular enlargement mostly involved the atria
and the posterior horns of the lateral ventricles; a
mild increase of the tip of the temporal horn was
observed in the 31-year-old male. Three AS patients
(25%) presented with periventricular white matter
hyperintensity; one patient also presented with
several small cortical cerebellar lesions and a left
caudate lacune (Figure 2).
Voxel-based morphometry
Significantly lower grey matter volume was found in
AS patients compared to controls (0.878 ± 0.122 vs.
1.023 ± 0.117 liters; F(1,25) = 18.50; p < 0.001 using age,
gender and global intracranial volume as covariates,
Figure 3) as described in Table 2. Similarly, white matter
volume decrease (0.591 ± 0.078 vs. 0.685 ± 0.108 liters;
F(1,25) = 13.85; p = 0.001 using age, gender and total
intracranial volume as covariates, Figure 3) was detected,
especially in the posterior regions.
By means of ROI analysis for hippocampal regions, a
significant differences in GM volume for both left and
right hippocampus was found. The difference persisted
after FDR correction only in the right hippocampus
(p = 0.046). ROI analysis conducted using total GM as
covariate showed clusters of significant difference in bothges of Alström syndrome patients. a) 31-year-old male: mild brain
r-old girl: enlargement of the left atrium of lateral ventricle;
Figure 2 Brain MRI of a 43-year-old male patient. Axial FLAIR (a, b); axial (c) and coronal (d) T1 weighted images. a,b) hyperintense rim
bordering the margin of both lateral ventricles and a small lacune in the left head of the caudate (arrow); c, d) multiple small hypointense lesions
in the cerebellar cortex.
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10) and right hippocampus (cluster-level FWE-corrected,
p = 0.050, peak: 12, -38, 10).DTI
TBSS analysis showed regions of significantly reduced
fractional anisotropy and increased radial diffusivity in AS
patients compared to controls (Figure 3). In particular, the
optic and acoustic radiation, body of the corpus callosum,
cingulum, fornix, centrum semiovale, limb of the internal
and external capsule were bilaterally affected. Noteworthy,
DTI white matter signal abnormalities also extended to
those supratentorial regions that appeared normal on con-
ventional MRI sequences. There were no white matter
regions where controls had significantly lower fractional
anisotropy values or increased radial diffusivity compared
to AS patients.Axial diffusivity and mean diffusivity were significantly
increased in the fornix of AS patients compared with
controls (Figure 3). There were no white matter regions
where controls had significantly higher mean diffusivity
and axial diffusivity.Discussion
This study showed that brain involvement is not uncom-
mon in AS patients. On conventional MRI sequences 50%
of AS patients presented brain abnormalities including
subtle signs of atrophy, periventricular WM abnormalities
or lacune-like lesions. Furthermore, VBM revealed white
and grey matter volume decrease more evident in the
posterior regions while diffusion tensor imaging showed
diffuse supratentorial white matter abnormalities
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Figure 3 TBSS and VBM analysis findings: colored areas show significant differences of Fractional Anisotropy, Radial Diffusivity, Axial Diffusivity,
Mean Diffusivity, gray matter and white matter volume between Alström patients and controls. Diffuse myelin supratentorial involvement and
regions of symmetric parenchymal atrophy.
Table 2 Differences in regional gray and white matter volumes between AS patients and controls
Brodmann Anatomical labelsa No. of voxels p-Value (FWE corrected)b MNI coordinates (mm)c
Grey Matter
BA22 LH Sup Temporal 35728 0,0001 −46 0 -4
LH Cerebellum 793 0,0001 −16 -40 -56
BA39 RH Middle temp gyrus 1187 0,0001 46 -74 22
BA10 RH Sup front Gyrus 1089 0,0001 32 58 22
BA39 LH Angular gyrus 860 0,0001 −46 -72 32
White Matter
BA17 RH Middle Occipital 6181 0,0001 −26 -98 6
BA19 LH Middle Occipital −24 -74 2
BA4 RH Precentral 3200 0,0001 42 -22 62
BA4 LH Middle cingulum −8 -32 46
RH Cerebellum 900 0,0001 24 -40 -48
aAnatomical labels were obtained using AAL Toolbox; sup = superior; temp = temporal; front = frontal.
b Statistical significance after correction for multiple comparisons (Family Wise Error voxel-level).
c Montreal Neurological Institute coordinates of the voxel of maximal statistical significance within each region.
LH = left hemisphere; RH = right hemispher.
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involvement was reported in a 6-year-old girl with AS
presenting with aphasia since birth and mild right
hemiparesis noted three months before admission [8].
Her brain CT revealed atrophy of the left hemisphere,
that according to the authors could have been a coinci-
dental association. Among our patients we had no cases
of hemiatrophy, although one patient presented with
diffuse mild atrophy and three presented with uni- or
bilateral ventricular enlargement without significant
increase of subarachnoid spaces. In all cases the
ventricular enlargement was more prominent in the
posterior part of the lateral ventricles. Likewise, VBM
showed a significant white matter and grey matter
volume reduction in AS patients, more evident in the
posterior cerebral regions.
Although posterior lateral ventricle enlargement has
been recognized in several clinical conditions, none of
the patients had history of prematurity, peripartum
anoxic-ischemic events or head trauma. Interestingly,
the posterior horns lie very close to the optic pathway
which is primarily affected in AS. A selective atrophy of
the optic pathway, therefore, could have contributed to
the atrophy of the posterior part of the cerebral
hemispheres, as observed in congenital and early blind-
ness [9,10].
In Bardet Biedl Syndrome (BBS) patients, focal tem-
poral lobe and midline orbitofrontal lobe grey matter
volume loss and hippocampal dysplasia were related to
a severe and global impact of ciliary dysfunction on
forebrain development [11,12]. Our study disclosed a
more diffuse lower grey matter volume without the
specific distribution detected in BBS patients. More-
over, no AS patient met the neuroimaging criteria for
hippocampal dysplasia. These findings seem to reveal
that brain involvement in these two ciliopathies is
dissimilar, thus providing some structural basis for the
known different cognitive impairment.
Three AS patients presented with periventricular
white matter hyperintensity. This type of lesion is fre-
quently observed in normal subjects but at a much older
age [13] and is attributed to altered hemodynamics since
periventricular area is supplied by noncollateralizing
ventriculofugal vessels arising from subependymal arter-
ies. Since up to 60% of AS subjects might present with
infant cardiomyopathy and sudden onset of cardiac
heart failure in their first month of life [1], parenchymal
brain changes might root from heart-related brain
hypoxia.
However, cardiac function usually improves before the
age of 3, while parenchymal changes seem to appear in AS
patients after the age of 30, thus suggesting a different
pathogenic mechanism. T2DM, hypercholesterolemia,
obesity and heart failure, which are frequent comorbiditiesin AS, might all contribute to decreased cerebral blood
flow, leading to early periventricular white matter
hyperintensity in AS patients.
In addition to periventricular white matter lesions, the
oldest male patient (43-year-old) had several lesions
consistent with small infarcts, almost all in the cerebellar
cortex. The pathogenesis of these lesions is unclear.
Global hypoperfusion and cardioembolism preferentially
involve the supratentorial structures and do not affect
almost exclusively the cerebellum as in our patient [14].
On the other hand, bilateral vertebral embolic sources in
the young (such as bilateral vertebral artery dissection) do
not usually occur without symptoms and would not
explain the lesion observed in the left internal carotid
artery territory (caudate nucleus). Alternatively, the
preferential involvement of the posterior circulation could
be related to AS itself. Ciliary involvement in endothelial
function has been demonstrated [15].
The presence of primary cilia in arteries with oscilla-
tory flow suggests a region-specific distribution.
These aspects could underlie a region-specific increased
susceptibility to risk factors present in AS. Indeed, other
inherited conditions (e.g. Fabry disease) present with an
increased risk of stroke in the posterior circulation,
unveiling a selective vulnerability to metabolic and vascular
factors of vertebro-basilar versus carotid territories [16].
Noteworthy, vascular-like lesions in AS patients seem to
appear as early as 30 years. Better management of cardiac
dysfunction will allow increasing survival of AS patients.
The expected wider range of brain involvement will prove
or deny the selective vulnerability of the vertebrobasilar
territory. Recently, an ischemic stroke in a 21-year-old
woman with Joubert syndrome has been reported,
suggesting that this condition might be at higher risk for
acute brain ischemia [17]. So far, no other ciliopathy has
been associated with an increased vulnerability to vascular
insults, but studies focused on this topic are lacking.
DTI evaluation added significant and unexpected infor-
mation on white matter involvement in AS. Diffuse
changes in radial diffusivity with almost no change in axial
diffusivity were observed both in highly anisotropic
regions, where the WM tracts are arranged as compact
fiber bundles (e.g. the corpus callosum) and in the less
anisotropic regions, where WM tracts are variably
intermingled. Similar findings have been reported in other
diseases characterized mostly by myelin derangement
such as relapsing remitting multiple sclerosis and in ani-
mal models of dysmyelination [18]. White matter frac-
tional anisotropy might be significantly and permanently
altered by severe infantile myopathy-related hypoxia.
However, neonatal hypoxia also alters permanently mean
and axial diffusivity [19]. AS patients did not present with
mean and axial diffusivity abnormalities (except from the
fornix). Moreover, hypoxia usually presents with cerebellar
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patients.
According to these findings hypoxia does not seem to
be able to explain supratentorial white matter changes in
AS.
Recently, adolescent patients affected with obesity and
metabolic syndrome have been shown to present small
white matter clusters of decreased FA suggesting a patho-
genic role of diabetes, hypertension and obesity in causing
early structural brain changes [21]. These changes were
limited (global volume of 4.47 mL), and not comparable
with the widespread supratentorial involvement observed
in our cohort.
Therefore, our findings uncover a diffuse and symmet-
ric supratentorial myelination abnormality. Intriguingly,
primary myelin issues have been already reported in the
peripheral nervous system of AS patients. Delamination
of the myelin sheaths was detected by transmission
electron microscopy at the level of the gingiva [22].
Recently, it has been shown that the primary cilia of
Schwann cells are the regulators of Hedgehog signaling-
mediated myelination in the peripheral nervous system,
[23,24] while genetic studies have shown that Sonic
Hedgehog signaling at the level of primary cilia is essen-
tial for patterning the embryonic stem cells into
oligodendrocytes [25,26]. Though the exact function of
cilia in brain development is unclear, expression of genes
involved in ciliary transport are seen in developing neural
tissues. A recent MRI study investigated the brain in BBS,
a ciliopathy that is clinically similar to AS with the
exceptions of polydactyly and learning deficits [27]. By
means of volumetric analisys, the study disclosed a
significant decrease of white matter volume, suggesting
a primary white matter involvement in this ciliopathy.
Our findings on AS patients, another ciliopathy that
does not feature impairment of cognitive performance,
seem to confirm the pivotal role of cilia in the embryo-
genic mechanism leading to white matter formation.
So far, TBSS has not been applied to investigate white
matter changes in BBS, Joubert Syndrome or Meckel-
Gruber Syndrome; therefore, it is not possible to clarify
whether the white matter involvement observed in AS
were a feature shared by other ciliopathies.
The peculiar signal change of the fornix in AS patients is
more difficult to unravel. In this region, AS patients had
increased mean and radial diffusivity consistent with axonal
involvement. It has been demonstrated that body mass
index correlates positively with mean and radial diffusivity
in the fornix [28]. Moreover, in several psychiatric diseases
(e.g. schizophrenia, anorexia nervosa) an involvement of
the fornix has been detected. Both these conditions (over-
weight or obesity and psychiatric disorders) have been
observed in AS and might underlie fornix DTI abnormal-
ities. In our group of AS patients ten of twelve wereoverweight or obese and four had psychiatric issues. On the
other hand, the fornix involvement could represent the ana-
tomical substrate leading to weight-related and psychiatry
disorders that have already reported in this disease [2].
Finally, AS patients might take several drugs to control
comorbidities. Some of these treatments could hypothetic-
ally have affected the abovementioned brain MRI findings.
Quetiapine has been shown to determine hippocampal
volume loss in schizophrenic patients, [29] while ris-
peridone has been reported to increase frontal lobe
intracortical myelin volume as detected by means of inver-
sion recovery and proton density weighted images [30]. In
our study group only one patient was treated with the
abovementioned drugs: the impact on the statistic should
be, therefore, negligible if any.
Two patients received omega-3 fatty acids. Omega-3
fatty acids have been demonstrated to protect against
cerobrovascular brain pathology and hippocampal volume
loss [31,32]. Given that VBM data and conventional MRI
disclosed mild hippocampal volume loss and increased
white matter lesion burden in AS patients compared to
age matched controls, a direct effect of omega-3 fatty
acids in determining these findings is unlikely.Conclusions
Alström syndrome patients present with mild brain
atrophy and vascular-like lesions at a very young age.
Additionally, DTI reveals supratentorial dysmyelination
which also entails the white matter that appears normal
on conventional MRI sequences. The role of cilia in
cerebral parenchymal changes and myelination needs
further investigation.
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